毕得医药
(688073)
| 流通市值：14.94亿 | | | 总市值：31.91亿 |
| 流通股本：4255.19万 | | | 总股本：9088.29万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,281,970,189.43 | 1,274,075,533.8 | 1,194,923,281.07 | 1,294,616,790.62 |
| 应收票据及应收账款 | 245,290,221.91 | 237,354,200.17 | 258,275,436.64 | 225,189,903.25 |
| 其中：应收票据 | 1,939,932.39 | 2,344,167.13 | 746,450 | 8,000 |
| 应收账款 | 243,350,289.52 | 235,010,033.04 | 257,528,986.64 | 225,181,903.25 |
| 预付款项 | 9,403,896.61 | 9,218,853.21 | 16,900,563.46 | 13,181,016.04 |
| 其他应收款合计 | 10,024,061.55 | 10,657,367.16 | 11,759,301.88 | 12,429,552.16 |
| 存货 | 670,410,703.61 | 699,430,441.56 | 695,582,434.09 | 631,887,939.75 |
| 其他流动资产 | 22,649,170.98 | 30,307,215.62 | 25,311,623.51 | 18,596,902.37 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,239,748,244.09 | 2,261,166,147.47 | 2,202,752,640.65 | 2,195,902,104.19 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | 43,253,079.52 | 41,626,539.76 |
| 固定资产 | 41,419,012 | 42,780,780.63 | 48,562,609.38 | 45,164,183.2 |
| 在建工程 | - | - | 6,619,461.33 | 2,742,915.93 |
| 使用权资产 | 48,090,758.4 | 54,540,850.96 | 49,289,841.14 | 53,617,984.02 |
| 无形资产 | 530,623.81 | 600,719.35 | 892,805.46 | 1,284,518.91 |
| 长期待摊费用 | 33,063,279.5 | 37,579,040.94 | 39,574,095.37 | 33,628,392.67 |
| 递延所得税资产 | 18,841,531.42 | 18,360,441.47 | 6,430,560.84 | 6,049,571.7 |
| 其他非流动资产 | 226,059.28 | - | 16,886,229.3 | 6,296,857.66 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 142,171,264.41 | 153,861,833.35 | 211,508,682.34 | 190,410,963.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,381,919,508.5 | 2,415,027,980.82 | 2,414,261,322.99 | 2,386,313,068.04 |
| 流动负债: | | | | |
| 短期借款 | 39,751,310.37 | 231,234.01 | 5,436,828.79 | 360,206.05 |
| 交易性金融负债 | 948,481.61 | 2,436,422.44 | 7,200,190.18 | 8,418,068.19 |
| 应付票据及应付账款 | 171,470,408.33 | 179,566,402.86 | 193,871,605.73 | 199,300,588.65 |
| 应付账款 | 171,470,408.33 | 179,566,402.86 | 193,871,605.73 | 199,300,588.65 |
| 合同负债 | 19,820,952.81 | 29,072,493.83 | 41,229,152.74 | 30,025,932.59 |
| 应付职工薪酬 | 21,120,531.62 | 21,560,093.25 | 13,839,758.03 | 14,582,573.09 |
| 应交税费 | 23,097,694.45 | 21,469,686.94 | 11,960,211.83 | 18,921,259.83 |
| 其他应付款合计 | 784,475.84 | 1,638,037.19 | 682,486.22 | 11,681,950.49 |
| 一年内到期的非流动负债 | 17,047,292.97 | 15,879,402.55 | - | - |
| 其他流动负债 | 2,477,147.05 | 3,116,329.81 | 4,443,911.67 | 3,891,400.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 296,518,295.05 | 274,970,102.88 | 278,664,145.19 | 287,181,979.01 |
| 非流动负债: | | | | |
| 租赁负债 | 32,041,407.43 | 41,185,511.52 | 51,649,666.77 | 54,915,604.1 |
| 预计负债 | - | 1,267,641.51 | - | - |
| 递延所得税负债 | 8,119,496.18 | 8,062,572.58 | 1,604,832.19 | 1,779,182.59 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 40,160,903.61 | 50,515,725.61 | 53,254,498.96 | 56,694,786.69 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 336,679,198.66 | 325,485,828.49 | 331,918,644.15 | 343,876,765.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 90,882,948 | 90,882,948 | 90,882,948 | 90,882,948 |
| 资本公积 | 1,753,930,769.57 | 1,753,537,094.5 | 1,752,169,492.31 | 1,751,886,657.95 |
| 减:库存股 | 70,431,395.78 | - | - | - |
| 其他综合收益 | -7,301,092.85 | -6,962,028.07 | -15,864,027.43 | -26,422,967.31 |
| 盈余公积 | 27,497,479.99 | 27,497,479.99 | 18,994,216.56 | 18,994,216.56 |
| 未分配利润 | 250,661,600.91 | 224,586,657.91 | 236,911,106.24 | 207,322,798.93 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,045,240,309.84 | 2,089,542,152.33 | 2,083,093,735.68 | 2,042,663,654.13 |
| 少数股东权益 | - | - | -751,056.84 | -227,351.79 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,045,240,309.84 | 2,089,542,152.33 | 2,082,342,678.84 | 2,042,436,302.34 |
| 负债和股东权益合计 | 2,381,919,508.5 | 2,415,027,980.82 | 2,414,261,322.99 | 2,386,313,068.04 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-28 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |